from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2777c/-

LFCtreatmentdescriptionclass of inhibitor

1.036

Amikacinug/mL Amikacintranslation

0.686

Cap5-10ug/mL Capreomycintranslation

2.086

Rox10-50 ug/mL Roxithromycintranslation

-0.421

SM2-5 ug/mL Streptomycintranslation

1.534

Tet5-10 ug/mL Tetracyclinetranslation

-1.181

Rif0.2-5ug/mL Rifampicintranscription

-0.640

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.877

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.935

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.582

CPZ10-50 ug/mL Chlorpromazinerespiration

0.524

Clofazimine10-13 ug/mL Clofaziminerespiration

0.211

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.131

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.520

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.996

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.448

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.374

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.405

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.635

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.678

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.561

KCN5-20 ug/mL Potassium cyaniderespiration

0.039

NaN30.2-2 mM Sodium aziderespiration

-0.546

Nigericin50 uM Nigericinrespiration

1.201

TRC10-150 ug/mL Triclosanrespiration

0.823

TRZ10-25 ug/mL Thioridazinerespiration

-0.842

Valinomycin0.5-10 uM Valinomycinrespiration

-0.963

ZnSO42 mM ZnSO4respiration

-0.784

menadione6-10 ug/mL Menadionerespiration

0.096

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.581

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.084

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.617

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.142

NRP_1Non-replicating persistence stage 1dosRassociated

-0.259

Amp0.2mg/mL AmpicillincellWall

-0.237

Cephalexin20-100 ug/mL CephalexincellWall

-0.898

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.018

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.973

EMB10-20 ug/mL EthambutolcellWall

-0.694

Eta12-40 ug/mL EthionamidecellWall

-0.601

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.288

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.433

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.006

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.137

BZA0.12 mg/mL BenzamidearomaticAmides

-0.090

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.314

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.715

H2O24 mM hydrogen peroxideDNAdamaging

-0.279

Levo10 ug/mL LevofloxacinDNAdamaging

-0.731

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.397

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.019

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.285

UVUV-irradiationDNAdamaging

-0.283

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.366

Antimycin12.5-50 ug/mL Antimycin A?

-0.597

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.740

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.176

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.265

PA8240.2-2 ug/mL PA-824?

-0.636

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.614

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.091

Verapamil50 uM Verapamil?

-0.429

mercaptoethanol2 mM 2-Mercaptoethanol?

0.153

methoxatin10-20 ug/mL Methoxatin?